REGISTERED NUMBER: SC245230 (Scotland)

Financial Statements for the Year Ended 31 March 2026

for

Kemnay Pharmacy Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Kenneth McDonald Manson

Mrs Lynn Iris Muriel Manson

Peter James Manson

Richard John Manson

SECRETARY:

Mrs Lynn Iris Muriel Manson

REGISTERED OFFICE:

18 North Silver Street

Aberdeen

AB10 1JU

REGISTERED NUMBER:

SC245230 (Scotland)

ACCOUNTANTS:

Tawse & Partners

Chartered Accountants

18 North Silver Street

Aberdeen

AB10 1JU

FIXED ASSETS

Intangible assets

5

680,638

945,611

Tangible assets

6

243,003

224,837

Investments

7

2,363,643

2,363,643

Investment property

8

229,330

-

3,516,614

3,534,091

CURRENT ASSETS

Stocks

210,367

193,864

Debtors

9

1,064,816

1,169,923

Prepayments and accrued income

20,802

23,099

Cash at bank and in hand

1,194,829

1,049,910

2,490,814

2,436,796

CREDITORS

Amounts falling due within one year

10

1,226,013

1,186,524

NET CURRENT ASSETS

1,264,801

1,250,272

TOTAL ASSETS LESS CURRENT LIABILITIES

4,781,415

4,784,363

CREDITORS

Amounts falling due after more than one year

11

(3,407,402

)

(3,762,180

)

PROVISIONS FOR LIABILITIES

(110,000

)

(54,950

)

NET ASSETS

1,264,013

967,233

CAPITAL AND RESERVES

Called up share capital

13

2

2

Retained earnings

1,264,011

967,231

SHAREHOLDERS' FUNDS

1,264,013

967,233

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 16 September 2026 and were signed on its behalf by:

Kenneth McDonald Manson - Director

1.	STATUTORY INFORMATION

Kemnay Pharmacy Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

The company's principal place of business is High Street, Kemnay, Aberdeenshire, AB51 5NB, 187 North Deeside Road, Peterculter, AB14 0UJ and 359 North Deeside Road, Cults, Aberdeen, AB15 9SX.

2.	STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3.	ACCOUNTING POLICIES

Accounting policies

The financial statements have been prepared under the historical cost convention.

The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year and have also been consistently applied within the same accounts.

Turnover recognition

Turnover is measured at fair value of the consideration received or receivable net of VAT and discounts. The policies adopted for the recognition of turnover are as follows:

Sale of goods

Turnover from the sale of goods is recognised when significant risks and rewards of ownership of the goods

have transferred to the buyer, the amount of turnover can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

When the outcome of a transaction can be estimated reliably, turnover from services rendered is recognised by reference to the stage of completion at the Statement of Financial Position date. Stage of completion is measured by reference to the NHS Income Statements at the Statement of Financial Position date.

Grants receivable

Depending on the type of grant, the income is either recognised in the period it is received or in the same period as the costs it relates to.

Goodwill

Purchased goodwill is capitalised and depreciated on a straight line basis over its useful economic life (not exceeding 20 years).

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tenants improvements

-

Over term of lease

Plant and equipment

-

20% on reducing balance

Motor vehicles

-

25% on cost

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Investment property

Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Stocks

Stocks are valued at the lower of cost and estimated selling price less costs to sell. Cost includes all costs of purchases, costs of conversion and other costs incurred in bring stock to its present location and condition. Provision is made for damaged, obsolete and slow-moving stock where appropriate.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 40 (2025 - 41 ) .

5.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 April 2025

and 31 March 2026

2,934,728

AMORTISATION

At 1 April 2025

1,989,117

Amortisation for year

264,973

At 31 March 2026

2,254,090

NET BOOK VALUE

At 31 March 2026

680,638

At 31 March 2025

945,611

6.	TANGIBLE FIXED ASSETS

Tenants

Plant and

Motor

improvements

equipment

vehicles

Totals

£

£

£

£

COST

At 1 April 2025

2,083

517,459

30,345

549,887

Additions

-

71,847

-

71,847

At 31 March 2026

2,083

589,306

30,345

621,734

DEPRECIATION

At 1 April 2025

2,083

306,077

16,890

325,050

Charge for year

-

48,932

4,749

53,681

At 31 March 2026

2,083

355,009

21,639

378,731

NET BOOK VALUE

At 31 March 2026

-

234,297

8,706

243,003

At 31 March 2025

-

211,382

13,455

224,837

7.	FIXED ASSET INVESTMENTS

Shares in

group

undertakings

£

COST

At 1 April 2025

and 31 March 2026

2,363,643

NET BOOK VALUE

At 31 March 2026

2,363,643

At 31 March 2025

2,363,643

8.	INVESTMENT PROPERTY

Total

£

FAIR VALUE

Additions

229,330

At 31 March 2026

229,330

NET BOOK VALUE

At 31 March 2026

229,330

9.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.26

31.3.25

£

£

Trade debtors

499,431

386,441

Amounts owed by group undertakings

493,567

724,436

Other debtors

71,818

59,046

1,064,816

1,169,923

10.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.26

31.3.25

£

£

Bank loans and overdrafts

346,466

336,692

Trade creditors

553,626

581,100

Taxation and social security

1,976

11,346

Other creditors

323,945

257,386

1,226,013

1,186,524

11.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31.3.26

31.3.25

£

£

Bank loans

3,407,402

3,762,180

Amounts falling due in more than five years:

Repayable by instalments

Bank loans more 5 yr by instal

1,996,934

2,391,760

12.	SECURED DEBTS

The following secured debts are included within creditors:

31.3.26

31.3.25

£

£

Bank loans

3,753,868

4,098,872

The banks holds a floating charge over the properties and the undertaking of the company.

13.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.3.26

31.3.25

value:

£

£

100

Ordinary Shares

£0.02

2

2